We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Globally Accurate Diagnostic Test Developed for Herpes

By LabMedica International staff writers
Posted on 25 Aug 2015
Print article
Image: Photomicrograph of the herpes simplex virus, within tissue taken from a penile lesion of a patient with genital herpes (Photo courtesy of the Centers of Disease Control and Prevention).
Image: Photomicrograph of the herpes simplex virus, within tissue taken from a penile lesion of a patient with genital herpes (Photo courtesy of the Centers of Disease Control and Prevention).
A universally accurate diagnostic test for human herpes simplex viruses (HSV) may soon be developed and that may also lead to the development of a vaccine that protects against the virus.

Currently, individuals are screened for HSV using a test that distinguishes between a glycoprotein, a molecule containing a carbohydrate and a protein present in HSV1, which is common throughout the population, and the considerably rarer HSV2. Whereas the test discriminates between the two variants with high accuracy in the USA and Europe, it largely fails in Africa, where rates of human immunodeficiency virus (HIV) and HSV are highest.

Scientists at National Institutes of Health (Bethesda, MD, USA) working with their academic colleagues and a team at Bioinfoexperts, LLC (Thibodaux, Louisiana, USA) used a variety of sequence analysis methods to compare all available sequence data for HSV-1 and HSV-2 glycoproteins, using viruses isolated in Europe, Asia, North America, the Republic of South Africa, and East Africa.

Published HSV-1 and HSV-2 glycoprotein sequences and their location data (when available) were downloaded from the Virus Pathogen Resource. Automated alignments were generated for each HSV species glycoprotein at the amino acid level and optimized by hand when necessary, after which the alignments were analyzed as nucleic acids. Alignments containing both HSV-1 and HSV-2 sequences for each glycoprotein were also generated.

The team reported that compared to HSV1, HSV2 has less genetic diversity. Besides providing clues to how the two strains evolved, the findings also have implications for vaccine development; because HSV2’s low genetic diversity means fewer antigens could be enough for developing a globally effective HSV2 vaccine. Because the current test discriminates between HSV1 and HSV2 by looking at variations in a localized region of so-called glycoprotein G, the team focused on the glycoproteins present in HSV by comparing the 36 HSV2 strains to 26 previously sequenced strains of HSV1 and looking at geographic diversity among the HSV2 glycoprotein sequences. They found that found that the African strains of glycoprotein G differed slightly from those in strains from other countries. Glycoproteins I and E also showed some variation.

Thomas C. Quinn, MD, a professor of medicine and coauthor of the study, said, “These variations explain why the diagnostic test didn’t work optimally in Africa. From this study, you then can make a consensus sequence that is common across the world for HSV2 glycoprotein that is different for HSV1 so you don’t get this misdiagnosis. It should now be possible to develop a more universal screening tool.” The studies were published in the August 2015 issue of the Journal of Virology.

Related Links:
National Institutes of Health 
Bioinfoexperts, LLC 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.